查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2018-2028年再生性傷口護理市場-全球行業規模、佔有率、趨勢、機會和預測，按類型、傷口類型、終端用戶、區域和競爭情況分類
市場調查報告書
商品編碼
1303143

2018-2028年再生性傷口護理市場-全球行業規模、佔有率、趨勢、機會和預測，按類型、傷口類型、終端用戶、區域和競爭情況分類

Regenerative Wound Care Market-Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type, By Wound Type, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 118 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球再生性傷口護理市場是由燒傷、損傷、瘡和潰瘍等引起的傷口發生率不斷增加所推動的。此外，日益成長的老年人口容易受到各種傷害和跌倒，預計將增加對再生傷口護理市場的需求。在老年人口中，由於各種其他相關條件，傷口癒合過程緩慢，導致對能夠帶來更快的傷口癒合的產品的需求，支持市場成長。根據聯合國經濟和社會事務部人口司的資料，到2050年，65歲或以上的人口數量預計將達到15.489億。

糖尿病病例不斷增加

糖尿病的發病率不斷增加，預計將增加對再生性傷口護理的需求。在包括中國和印度在內的幾個發展中國家，糖尿病已經成為一種流行病。糖尿病會增加傷口的總體發病率和複雜性，特別是感染、慢性傷口和潰瘍。這需要治療並產生高昂的醫療費用。世界衛生組織（WHO）報告指出，2019年非傳染性疾病造成74%的死亡；糖尿病造成160萬人死亡，是全球第九大死因。在全球範圍內以及像印度這樣的新興國家，糖尿病的負擔很大，而且還在上升，主要是由於超重/肥胖率上升和不健康的生活方式。眾多因素，如異常的高血糖，可能會損害血管和神經。這減少了流向手、腳和腿的血流量，這使得傷口和潰瘍更難癒合。美國疾病控制和預防中心（CDC）估計，在美國約有3730萬人患有糖尿病，佔人口的11.3%。糖尿病還可能導致糖尿病神經病變，而影響傷口癒合。

燒傷、事故、傷害的發生率增加

由於手術、事故和受傷等原因造成的傷口發生率不斷增加，大幅增加了對再生性傷口護理的需求。全球第十大死因是道路交通事故，這也是最常見的，因為有幾個因素，如超速；在酒精和其他精神活性物質影響下駕駛；不使用摩托車頭盔、安全帶和兒童安全座椅；分心駕駛；不安全的車輛；碰撞後護理不足和交通法規執法不力。世衛組織估計，每年有130多萬人因道路交通事故而喪生。另有2000萬至5000萬人受到非致命性傷害，其中許多人因此而成為殘疾人。

最近的發展情況

全球再生性傷口護理市場見證許多新的發展，包括合併和收購、推出新產品、啟動新的臨床試驗、增加研發活動和進行投資等，以保持競爭力，並在市場上的其他參與者中佔據優勢。

  • 2021年6月，MiMedx Group, Inc.獲得日本厚生勞動省批准其產品Epifix在日本進行商業化。
  • 2019年5月，Organogenesis Inc.與Vizient, Inc.達成了一項協議。這又幫助Organogenesis公司增加了其傷口護理產品的供應，提高了其市場定位。

可用的客製化服務

利用給定的市場資料，TechSci Research根據公司的具體需求提供客製化服務。本報告有以下客製化選項：

公司資訊

  • 其他市場參與者（最多5家）的詳細分析和概況。

目錄

第一章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究涵蓋的年份
    • 關鍵的市場細分

第二章：研究方法

  • 研究的目的
  • 基線方法
  • 主要行業合作夥伴
  • 主要協會和二級來源
  • 預測方法
  • 資料三角測量和驗證
  • 假設和限制

第三章：執行摘要

  • 市場概述
  • 主要市場細分概述
  • 主要市場參與者概述
  • 主要地區/國家概況
  • 市場驅動因素、挑戰、趨勢概述

第四章：客戶的聲音

第五章：臨床試驗分析

  • 進行的臨床試驗
  • 已完成的臨床試驗
  • 終止的臨床試驗
  • 按開發階段分類的管線細目
  • 按狀態分類的管線細目
  • 按研究應用分類的管線細目
  • 按地區分類的管線細目
  • 臨床試驗熱圖

第六章：全球再生性傷口護理市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率與預測
    • 按類型（自體幹細胞、生物皮膚替代品、組織/多組織平台、胎兒皮膚、再生傷口護理設備、其他）分類
    • 按傷口類型（潰瘍、手術和創傷性傷口、燒傷）分類
    • 按終端用戶（醫院、非住院手術中心、燒傷護理中心和傷口診所、其他）分類
    • 按地區分類
    • 按公司分類(2022年)
  • 市場地圖

第七章：北美再生性傷口護理市場展望

  • 市場規模和預測
    • 按價值分類
  • 市場佔有率與預測
    • 按類型（自體幹細胞、生物皮膚替代品、組織/多組織平台、胎兒皮膚、設備、其他）分類
    • 按傷口類型（潰瘍、手術和創傷性傷口、燒傷）分類
    • 按終端用戶（醫院、非住院手術中心、燒傷護理中心和傷口診所、其他）分類
    • 按國家分類
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第8章：歐洲再生性傷口護理市場前景

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率與預測
    • 按類型（自體幹細胞、生物皮膚替代品、組織/多組織平台、胎兒皮膚、設備、其他）分類
    • 按傷口類型（潰瘍、手術和創傷性傷口、燒傷）分類
    • 按終端用戶（醫院、非住院手術中心、燒傷護理中心和傷口診所、其他）分類
    • 按國家分類
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第九章：亞太地區再生性傷口護理市場展望

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率與預測
    • 按類型（自體幹細胞、生物皮膚替代品、組織/多組織平台、胎兒皮膚、設備、其他）分類
    • 按傷口類型（潰瘍、手術和創傷性傷口、燒傷）分類
    • 按終端用戶（醫院、非住院手術中心、燒傷護理中心和傷口診所、其他）分類
    • 按國家分類
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第十章：南美再生性傷口護理市場前景

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率與預測
    • 按類型（自體幹細胞、生物皮膚替代品、組織/多組織平台、胎兒皮膚、設備、其他）分類
    • 按傷口類型（潰瘍、手術和創傷性傷口、燒傷）分類
    • 按終端用戶（醫院、非住院手術中心、燒傷護理中心和傷口診所、其他）分類
    • 按國家分類
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第11章：中東和非洲再生性傷口護理市場展望

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率與預測
    • 按類型（自體幹細胞、生物皮膚替代品、組織/多組織平台、胎兒皮膚、再生傷口護理設備、其他）分類
    • 按傷口類型（潰瘍、手術和創傷性傷口、燒傷）分類
    • 按終端用戶（醫院、非住院手術中心、燒傷護理中心和傷口診所、其他）分類
    • 按國家分類
  • MEA: 國家分析
    • 南非再生性傷口護理
    • 沙烏地阿拉伯再生性傷口護理
    • 阿拉伯聯合大公國再生性傷口護理

第十二章：市場動態

  • 驅動力
  • 挑戰

第十三章：市場趨勢與發展

  • 最近的發展情況
  • 合併和收購
  • 產品發布

第十四章：競爭格局

  • 業務概況
  • 公司簡介
  • 產品與服務
  • 財務狀況（如報告所示）
  • 近期發展
  • SWOT分析
    • DeCell Technologies Inc.
    • Avita Medical, Inc.
    • Organogenesis, Inc.
    • Histogen, Inc.
    • RenovoDerm (Nanofiber Solutions, LLC)
    • StemsysBio
    • Koninklijke DSM NV
    • MiMedx Group, Inc.

第十五章：戰略建議

簡介目錄
Product Code: 14405

Global Regenerative Wound Care Market is driven by the growing incidence of wounds caused due to burns, injuries, soars & ulcers, among others. Additionally, a growing geriatric population that is susceptible to various kinds of injuries and falls is expected to increase the demand for the regenerative wound care market. In the elderly population, due to various other associated conditions, the wound healing process is slow, leading to the demand for products that can bring about faster wound healing, thereby supporting market growth. According to the United Nations Department of Economic and Social Affairs, Population Division, the number of persons aged 65 years or above is expected to reach 1548.9 million by 2050.

The growing number of surgical procedures performed, along with increasing incidences of chronic burns, is further expected to increase the demand for the regenerative wound care market. Furthermore, the growing prevalence of diabetes is expected to fuel market growth in the coming years. Moreover, increasing research & development and new product approvals & launches are further expected to create lucrative opportunities for market growth. According to clinicaltrials.gov, as of 12th December, there are around 57 clinical trials registered across the globe related to regenerative wound care, which is in different phases of development worldwide. This, in turn, has led to the development and launch of new products. Organogenesis, Inc. was the first company to receive FDA approvals for a living, human cell-based product, Apligraf, and Dermagraft.

Apligraf is bioengineered with living cells that are bioactive to transform wounds from chronic to acute. Apligraf has illustrated clinical evidence in the treatment of Healing Venous Leg Ulcers and Diabetic Foot Ulcers. Apligraf resembles and functions like healthy human skin. Similarly, Dermagraft is a sterile, cryopreserved, human fibroblast-derived dermal substitute generated by the culture of neonatal dermal fibroblasts onto a bioabsorbable polyglactin mesh scaffold for the treatment of Diabetic Foot Ulcer in the United States.

Increasing cases of diabetes

The growing prevalence of diabetes is expected to increase the demand for regenerative wound care. Diabetes has become a pandemic in several developing nations, including China and India. Diabetes can increase the overall incidence and complexity of wounds, especially infections, chronic wounds, and ulcerations. This requires treatment and incurs exorbitant medical expenses. The World Health Organization (WHO) reports that non-communicable diseases caused 74% of deaths in 2019; diabetes killed 1.6 million people, making it the ninth largest cause of death worldwide. Globally and in emerging nations like India, the burden of diabetes is large and rising, primarily due to rising rates of overweight/obesity and unhealthy lifestyles. Numerous factors, such as abnormally high blood sugar, might damage blood vessels and nerves. This reduces blood flow to the hands, feet, and legs, which makes it more difficult for cuts and sores to heal. The Centers for Disease Control and Prevention (CDC) estimates that about 37.3 million people in the United States, or 11.3% of the population, have diabetes. Diabetes can also cause diabetic neuropathy, which can affect wound healing.

Increase in Incidences of Burns, Accidents, Injuries

The growing incidences of wounds caused due to surgeries, accidents, and injuries, among others, have significantly increased the demand for regenerative wound care. The tenth biggest cause of death globally is road traffic accidents, which are also the most common due to several factors such as speeding; driving under the influence of alcohol and other psychoactive substances; no-use of motorcycle helmets, seatbelts, and child restraints; distracted driving; unsafe vehicle; inadequate post-crash care and inadequate law enforcement of traffic laws. The WHO estimates that every year road traffic accidents claim the lives of over 1.3 million people. Between 20 and 50 million additional people have non-fatal injuries, with many of them becoming disabled as a result.

Market Segmentation

Global Regenerative Wound Care Market can be segmented by type, by wound type, by end-user, and by region. Based on type, the market can be categorized into autologous stem cells, biological skin substitutes, tissue/multiple tissue platforms, fetal skin, regenerative wound care devices, and others. Based on wound type, the market can be fragmented into ulcers, surgical & traumatic wounds, and burns. Ulcers can further be divided into diabetic foot ulcers, pressure ulcers, and others. Based on end-user, the market can be grouped into hospitals, ambulatory surgical centers, burn care centers & wound clinics, and others. Regionally, the market can be segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa.

Market Players

DeCell Technologies Inc., Avita Medical, Inc., Organogenesis, Inc., Histogen, Inc., RenovoDerm (Nanofiber Solutions, LLC), StemsysBio, Koninklijke DSM N.V., MiMedx Group, Inc., among others, are some of the leading players operating in the global regenerative wound care market.

Recent Developments

Global Regenerative Wound Care Market is witnessing a lot of new developments in the form of mergers & acquisitions, new product launches, launching new clinical trials, increasing research & development activities, and making investments, among others, in order to stay competitive and an edge over the other players operating in the market.

  • In June 2021, MiMedx Group, Inc. received approval for the commercialization of its product Epifix in Japan from the Japanese Ministry of Health, Labour, and Welfare.
  • In May 2019, Organogenesis Inc. entered into an agreement with Vizient, Inc. This, in turn, helped Organogenesis increase its wound care product offerings and improve its market positioning.

Report Scope

In this report, Global Regenerative Wound Care Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Regenerative Wound Care Market, By type:

  • Autologous Stem Cells
  • Biological Skin Substitutes
  • Tissue/Multiple Tissue Platform
  • Fetal Skin
  • Regenerative Wound Care Devices
  • Others

Regenerative Wound Care Market, By Wound Type:

  • Ulcers
  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Others
  • Surgical & Traumatic Wounds
  • Burns

Regenerative Wound Care Market, By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Burn Care Centers & Wound Clinics
  • Others

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Regenerative Wound Care Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

  • 5.1. Ongoing Clinical Trials
  • 5.2. Completed Clinical Trials
  • 5.3. Terminated Clinical Trials
  • 5.4. Breakdown of Pipeline, By Development Phase
  • 5.5. Breakdown of Pipeline, By Status
  • 5.6. Breakdown of Pipeline, By Study Application
  • 5.7. Breakdown of Pipeline, By Region
  • 5.8. Clinical Trials Heat Map

6. Global Regenerative Wound Care Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Autologous Stem Cells, Biological Skin Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative Wound Care Devices, Others)
    • 6.2.2. By Wound Type (Ulcers, Surgical & Traumatic Wounds, Burns)
      • 6.2.2.1. By Ulcers (Diabetic Foot Ulcers, Pressure Ulcers, Others)
    • 6.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Burn Care Centers & Wound Clinics, Others)
    • 6.2.4. By Region
    • 6.2.5. By Company (2022)
  • 6.3. Market Map

7. North America Regenerative Wound Care Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type (Autologous Stem Cells, Biological Skin Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative Wound Care Devices, Others)
    • 7.2.2. By Wound Type (Ulcers, Surgical & Traumatic Wounds, Burns)
      • 7.2.2.1. By Ulcers (Diabetic Foot Ulcers, Pressure Ulcers, Others)
    • 7.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Burn Care Centers & Wound Clinics, Others)
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Regenerative Wound Care Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Wound Type
        • 7.3.1.2.3. By End User
    • 7.3.2. Canada Regenerative Wound Care Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Wound Type
        • 7.3.2.2.3. By End User
    • 7.3.3. Mexico Regenerative Wound Care Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Wound Type
        • 7.3.3.2.3. By End User

8. Europe Regenerative Wound Care Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. B By Type (Autologous Stem Cells, Biological Skin Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative Wound Care Devices, Others)
    • 8.2.2. By Wound Type (Ulcers, Surgical & Traumatic Wounds, Burns)
      • 8.2.2.1. By Ulcers (Diabetic Foot Ulcers, Pressure Ulcers, Others)
    • 8.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Burn Care Centers & Wound Clinics, Others)
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Regenerative Wound Care Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Wound Type
        • 8.3.1.2.3. By End User
    • 8.3.2. Germany Regenerative Wound Care Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Wound Type
        • 8.3.2.2.3. By End User
    • 8.3.3. United Kingdom Regenerative Wound Care Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Wound Type
        • 8.3.3.2.3. By End User
    • 8.3.4. Italy Regenerative Wound Care Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Wound Type
        • 8.3.4.2.3. By End User
    • 8.3.5. Spain Regenerative Wound Care Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Wound Type
        • 8.3.5.2.3. By End User

9. Asia-Pacific Regenerative Wound Care Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type (Autologous Stem Cells, Biological Skin Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative Wound Care Devices, Others)
    • 9.2.2. By Wound Type (Ulcers, Surgical & Traumatic Wounds, Burns)
      • 9.2.2.1. By Ulcers (Diabetic Foot Ulcers, Pressure Ulcers, Others)
    • 9.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Burn Care Centers & Wound Clinics, Others)
    • 9.2.4. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Regenerative Wound Care Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Wound Type
        • 9.3.1.2.3. By End User
    • 9.3.2. India Regenerative Wound Care Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Wound Type
        • 9.3.2.2.3. By End User
    • 9.3.3. Japan Regenerative Wound Care Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Wound Type
        • 9.3.3.2.3. By End User
    • 9.3.4. South Korea Regenerative Wound Care Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Wound Type
        • 9.3.4.2.3. By End User
    • 9.3.5. Australia Regenerative Wound Care Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Wound Type
        • 9.3.5.2.3. By End User

10. South America Regenerative Wound Care Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type (Autologous Stem Cells, Biological Skin Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative Wound Care Devices, Others)
    • 10.2.2. By Wound Type (Ulcers, Surgical & Traumatic Wounds, Burns)
      • 10.2.2.1. By Ulcers (Diabetic Foot Ulcers, Pressure Ulcers, Others)
    • 10.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Burn Care Centers & Wound Clinics, Others)
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Regenerative Wound Care Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Wound Type
        • 10.3.1.2.3. By End User
    • 10.3.2. Argentina Regenerative Wound Care Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Wound Type
        • 10.3.2.2.3. By End User
    • 10.3.3. Colombia Regenerative Wound Care Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Wound Type
        • 10.3.3.2.3. By End User

11. Middle East and Africa Regenerative Wound Care Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type (Autologous Stem Cells, Biological Skin Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative Wound Care Devices, Others)
    • 11.2.2. By Wound Type (Ulcers, Surgical & Traumatic Wounds, Burns)
      • 11.2.2.1. By Ulcers (Diabetic Foot Ulcers, Pressure Ulcers, Others)
    • 11.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Burn Care Centers & Wound Clinics, Others)
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Regenerative Wound Care Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Wound Type
        • 11.3.1.2.3. By End User
    • 11.3.2. Saudi Arabia Regenerative Wound Care Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Wound Type
        • 11.3.2.2.3. By End User
    • 11.3.3. UAE Regenerative Wound Care Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Wound Type
        • 11.3.3.2.3. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

  • 13.1. Recent Developments
  • 13.2. Mergers & Acquisitions
  • 13.3. Product Launches

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Company Snapshot
  • 14.3. Products & Services
  • 14.4. Financials (As Reported)
  • 14.5. Recent Developments
  • 14.6. SWOT Analysis
    • 14.6.1. DeCell Technologies Inc.
    • 14.6.2. Avita Medical, Inc.
    • 14.6.3. Organogenesis, Inc.
    • 14.6.4. Histogen, Inc.
    • 14.6.5. RenovoDerm (Nanofiber Solutions, LLC)
    • 14.6.6. StemsysBio
    • 14.6.7. Koninklijke DSM N.V.
    • 14.6.8. MiMedx Group, Inc.

15. Strategic Recommendations